- Significant sales and earnings increases
- Key orders in the segments Life Science and Semiconductor
- Order backlog at € 105.6 million as of September 2021
- Gross margin develops positively at 29.2 %
- Audit certificate for the 2020 annual financial statement still outstanding
- Entry into the field of thin-film solar modules CdTe with first orders for production plants
Kahl am Main, November 11, 2021 – In the first nine months SINGULUS TECHNOLOGIES was able to increase sales from € 21.9 million in the prior-year period to € 45.5 million this year. The operating earnings before interest and taxes (EBIT) for the first amounted to € -7.6 million (previous year: € -20.6 million). In the 3rd quarter a positive EBIT in the amount of € 0.3 million (previous year: € -6.3 million) was achieved.
During the first nine months of the business year 2021 the order intake came to € 73.3 million, above the prior-year level of € 70.9 million in 2020. As of September 30, 2021, the order backlog was also increased compared with the previous year and currently amounts to € 105.6 million (previous year: € 75.3 million). Significant incoming orders in October further increase the order backlog. Here, the signing of contracts for machines for the production of thin-film solar modules with China Triumph International Engineering Co. Ltd. (CTIEC), Shanghai, China, a subsidiary of the China National Building Materials Group (CNBM), Beijing, China, stands out. The concluded order includes the delivery of production machines for manufacturing sites for the production of both CdTe and CIGS thin-film solar modules through sputtering, vaporization and sublimation.
Dr. Stefan Rinck, CEO SINGULUS TECHNOLOGIES: “With the order for CdTe production plants, we were able to successfully expand our positioning in the thin-film sector.“ The total order value amounts to approximately € 25 million. On the basis of the contractual agreements, the planned prepayments are expected to be received in the course of November 2021.
The liquid funds of SINGULUS TECHNOLOGIES amounted to € 13.3 million as of September 30, 2021 compared to € 9.8 million at
December 31, 2020. In the 2021 reporting period, the gross margin developed significantly positively due to increased capacity utilization and the changed product mix within production and amounted to 29.2 % (previous year:
As an internationally operating company SINGULUS TECHNOLOGIES is monitoring the current developments in connection with the COVID-19 pandemic in the business year 2021 as well. The Executive Board of SINGULUS TECHNOLOGIES expects that the impacts of the COVID-19 pandemic will continue to have an impact on the company.
The further economic development of the company materially depends on the global business activities in all segments, the order intake as well as the resulting payments. However, the attestation by the appointed auditor for the consolidated financial statements for the business year 2020 drawn up by SINGULUS TECHNOLOGIES is still pending, because the required going-concern assumption is currently not sufficiently grounded from the auditor’s perspective. The going-concern assumption of the company materially depends on the economic development, supported by additional order intake, as well as the sufficient financing for the following two business years.
In addition, to further strengthen the liquidity, the company is currently negotiating, with support from the Chinese main shareholder CNBM with Chinese commercial banks about the provision of an additional working capital line of credit in the amount of up to € 10.0 million.
This also includes the successful refinancing of the still outstanding, senior-secured loan in the amount of € 4.0 million.
The Executive Board expects a favorable conclusion of the talks in the course of the fourth quarter 2021. Furthermore, incoming orders are still required for the next few weeks. The advance payments for the contracts signed on October 29, 2021 must be collected as planned.
Upon reaching these goals, the Executive Board expects the receipt of the attestation in the remaining course of the fourth quarter 2021.
In the past couple of months the company experienced a significant recovery of the business activities with a resulting substantial increase in the order intake. Accordingly, a slightly positive EBIT was already achieved in the third quarter 2021.The Executive Board expects this trend to continue in the fourth quarter 2021. However, due to the high proportion of customer-specific projects, key financial figures, such as sales revenues and EBIT, are highly dependent on the contractual receipt of the supplier parts of our suppliers.
SINGULUS TECHNOLGOIES Group key figures for nine months (unaudited)
|Sales (gross)||million €||21.9||45.5|
|Order intake||million €||70.9||73.3|
|Order backlog (Sept. 30)||million €||75.3||105.6|
|Earnings before taxes||million €||-22.2||-9.1|
|Net profit/loss||million €||-21.4||-9.0|
|Operating cash flow||million €||3.6||14.4|
|Shareholders’ equity||million €||-14.6||-42.7|
|Balance sheet total||million €||75.7||76.0|
|Research & development expenses||million €||8.1||7.2|
|Employees (Sept. 30)||355||338|
|Weighted average shares outstanding, basic||8.896,527||8.896,527|
|Earnings per share, basic||€||-2.41||-1.01|
SINGULUS TECHNOLOGIES – Technologies for a Sustainable World
Responsible and sustainable corporate governance is very important to SINGULUS TECHNOLOGIES. SINGULUS TECHNOLOGIES develops and assembles innovative machines and systems for efficient and resource-saving production processes, which are used worldwide in the solar/hydrogen, semiconductor, medical technology, consumer goods and data storage sectors. SINGULUS TECHNOLOGIES regards sustainability as an opportunity to position itself with innovative products that follow this spirit.
In the focus are:
- environmental awareness
- efficient use of resources
- avoidance of unnecessary CO2pollution
The company’s core competencies include various processes of coating technology, surface treatment and wet-chemical and thermal production processes.
SINGULUS TECHNOLOGIES AG, Hanauer Landstraße 103,
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5
Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279
Bernhard Krause, Corporate Communications, Tel.: +49 (0)172 833 2224